Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors.

VTE rates were higher among NSCLC patients treated with platinum-based chemotherapy than those treated with ICI alone, though the precision of the relative estimate is low. The KS did not identify high-risk ICI-treated patients, suggesting that an ICI-specific risk model is warranted.